Status:
COMPLETED
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Lead Sponsor:
Washington University School of Medicine
Conditions:
Uterine Cervical Neoplasms
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
Brief Summary
Indications for post-hysterectomy radiation therapy (RT) have been well established by clinical data. Adjuvant RT has demonstrated local control and survival benefit. In patients with nodal disease, a...
Detailed Description
Patients with cervical cancer receiving post-operative radiotherapy (RT) for high risk features found on pathologic review will be treated with pelvic intensity modulated radiation therapy (IMRT). Hel...
Eligibility Criteria
Inclusion
- Age \>= 18
- Karnofsky Performance Status of \>= 60
- FIGO Stage I -IIB
- Pathologic confirmation of cervical cancer
- Status post hysterectomy
- Patients with local or regional metastases are eligible for this protocol, but not those with distant metastases
Exclusion
- Age \< 18
- Karnofsky Performance Status \< 60
- Radiographic or pathologic evidence of distant metastatic disease
- Prior pelvic radiation therapy, other than trans-vaginal ring brachytherapy irradiation for acute hemostasis
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00359866
Start Date
February 1 2006
End Date
January 1 2016
Last Update
June 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110